Cordis Sa

Salta A4400ANW

0 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Disease, Coronary Heart Disease (CHD), Lupus Erythematosus, Systemic, Systemic Lupus Erythematosus

Studies at this site

• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed